Table 1.
Demographic and Clinical Characteristics
| Total (n=71) | |
|---|---|
| Age (years), mean ± SD | 47.4 ± 14.9 |
| Sex (female), n (%) | 57 (80.3) |
| Education (university), n (%) | 30 (42.2) |
| Living with family members or a partner, n (%) | 63 (90) |
| Employment status (part or full-time employed), n (%) | 21 (30) |
| Disease duration (years), mean ± SD | 9.9 ± 8.1 |
| Onset attack type, n (%) | |
| Myelitis | 34 (47.8) |
| Optic neuritis | 27 (38) |
| Myelitis + optic neuritis | 3 (4.2) |
| Other | 7 (9.8) |
| Relapsing form, n (%) | 59 (83.1) |
| Number of relapses since diagnosis, mean ± SD | 2.9 ± 2.3 |
| Number of relapses in the last year, mean ± SD | 0.5 ± 0.9 |
| Coexisting autoimmune disease, n (%) | 21 (29.6) |
| EDSS score, median (IQR) | 3.0 (1.5, 4.5) |
| Physical impact MSIS-29 score, mean ± SD | 41.9 ± 16.7 |
| Psychological impact MSIS-29 score, mean ± SD | 20.9 ± 8.3 |
| MOS-PES score, mean ± SD | 13.9 ± 6.3 |
| D-FIS score, mean ± SD | 9.0 ± 8.3 |
| BDI-FS score, mean ± SD | 3.6 ± 3.4 |
| Patients with depression, n (%) | 31 (43.6) |
| Patients with moderate to severe depression, n (%) | 8 (11.2) |
Abbreviations: BDI-FS, Beck Depression Inventory-Fast Screen; D-FIS, Fatigue Impact Scale for Daily Use; EDSS, Expanded Disability Status Scale; IQR, interquartile range; MOS-PES, Pain Effects Scale; MSIS-29, 29-item Multiple Sclerosis Impact Scale; SD, standard deviation.